Viking Therapeutics, Inc. (VKTX)
34.32
+3.62
(+11.81%)
USD |
NASDAQ |
Jan 14, 16:00
34.59
+0.28
(+0.80%)
After-Hours: 20:00
Viking Therapeutics Rent and Landing Expense (Quarterly)
Rent and Landing Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Rent and Landing Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Rent and Landing Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | -- |
| Pfizer Inc. | -- |
| Amgen, Inc. | -- |
| Altimmune, Inc. | -- |
| Moderna, Inc. | -- |